{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:58:06Z","timestamp":1787025486081,"version":"build-2736575974"},"reference-count":41,"publisher":"Society of Nuclear Medicine","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.2967\/jnumed.120.245381","type":"journal-article","created":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T23:49:35Z","timestamp":1591055375000},"page":"965-970","source":"Crossref","is-referenced-by-count":44,"title":["Molecular Imaging of Cardiac Amyloidosis"],"prefix":"10.2967","volume":"61","author":[{"given":"Ahmad","family":"Masri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed","family":"Bukhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne S.","family":"Eisele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prem","family":"Soman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2020,6,1]]},"reference":[{"key":"2021051712150072000_61.7.965.1","unstructured":"Orphan drug regulations: regulatory history. U.S. Food and Drug Administration website. http:\/\/www.fda.gov\/ForIndustry\/DevelopingProductsforRareDiseasesConditions\/HowtoapplyforOrphanProductDesignation\/ucm356481.htm. Revised February 28, 2018. Accessed June 5, 2020."},{"key":"2021051712150072000_61.7.965.2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018016402"},{"key":"2021051712150072000_61.7.965.3","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.carpath.2015.07.008","article-title":"Cardiac amyloidosis: pathology, nomenclature, and typing","volume":"24","author":"Maleszewski","year":"2015","journal-title":"Cardiovasc Pathol."},{"key":"2021051712150072000_61.7.965.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra023144"},{"key":"2021051712150072000_61.7.965.5","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0912263107"},{"key":"2021051712150072000_61.7.965.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(19)33478-3"},{"key":"2021051712150072000_61.7.965.7","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.024438"},{"key":"2021051712150072000_61.7.965.8","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1093\/eurheartj\/ehx043","article-title":"Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disproving myths","volume":"38","author":"Gonz\u00e1lez-L\u00f3pez","year":"2017","journal-title":"Eur Heart J."},{"key":"2021051712150072000_61.7.965.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2009.08.008"},{"key":"2021051712150072000_61.7.965.10","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000416"},{"key":"2021051712150072000_61.7.965.11","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.021612"},{"key":"2021051712150072000_61.7.965.12","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1007\/s00259-018-4013-4","article-title":"Diagnostic accuracy of bone scintigraphy in the assessment of cardiac transthyretin-related amyloidosis: a bivariate meta-analysis","volume":"45","author":"Treglia","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021051712150072000_61.7.965.13","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.carpath.2016.07.001","article-title":"Varying levels of small microcalcifications and macrophages in ATTR and AL cardiac amyloidosis: implications for utilizing nuclear medicine studies to subtype amyloidosis","volume":"25","author":"Stats","year":"2016","journal-title":"Cardiovasc Pathol."},{"key":"2021051712150072000_61.7.965.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.05.073"},{"key":"2021051712150072000_61.7.965.15","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1007\/s12350-019-01760-6","article-title":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2\u2014evidence base and standardized methods of imaging","volume":"26","author":"Dorbala","year":"2019","journal-title":"J Nucl Cardiol."},{"key":"2021051712150072000_61.7.965.16","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.112.000132"},{"key":"2021051712150072000_61.7.965.17","doi-asserted-by":"crossref","first-page":"e010249","DOI":"10.1161\/CIRCIMAGING.119.010249","article-title":"Efficient 1-hour technetium-99 m pyrophosphate imaging protocol for the diagnosis of transthyretin cardiac amyloidosis","volume":"13","author":"Masri","year":"2020","journal-title":"Circ Cardiovasc Imaging."},{"key":"2021051712150072000_61.7.965.18","doi-asserted-by":"publisher","DOI":"10.1021\/jm030026b"},{"key":"2021051712150072000_61.7.965.19","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-014-2787-6"},{"key":"2021051712150072000_61.7.965.20","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.169870"},{"key":"2021051712150072000_61.7.965.21","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s00259-019-04290-y","article-title":"Detection of cardiac amyloidosis with 18F-Florbetaben-PET\/CT in comparison to echocardiography, cardiac MRI and DPD-scintigraphy","volume":"46","author":"Kircher","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021051712150072000_61.7.965.22","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.111.102053"},{"key":"2021051712150072000_61.7.965.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2014.09.018"},{"key":"2021051712150072000_61.7.965.24","doi-asserted-by":"crossref","unstructured":"Park MA Padera RF Belanger A . 18F-florbetapir binds specifically to myocardial light chain and transthyretin amyloid deposits: autoradiography study. Circ Cardiovasc Imaging. 2015;8:10.1161\/CIRCIMAGING.114.002954.","DOI":"10.1161\/CIRCIMAGING.114.002954"},{"key":"2021051712150072000_61.7.965.25","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1007\/s12350-017-0799-x","article-title":"18Fluorine sodium fluoride positron emission tomography, a potential biomarker of transthyretin cardiac amyloidosis","volume":"25","author":"Morgenstern","year":"2018","journal-title":"J Nucl Cardiol."},{"key":"2021051712150072000_61.7.965.26","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.106.039313"},{"key":"2021051712150072000_61.7.965.27","first-page":"261","article-title":"Re-evaluating the potentials and limitations of 99mTc-aprotinin scintigraphy for amyloid imaging","volume":"3","author":"Minamimoto","year":"2013","journal-title":"Am J Nucl Med Mol Imaging."},{"key":"2021051712150072000_61.7.965.28","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-03-273797"},{"key":"2021051712150072000_61.7.965.29","doi-asserted-by":"crossref","first-page":"5008","DOI":"10.1038\/s41467-019-13038-z","article-title":"Cryo-EM structure of a transthyretin-derived amyloid fibril from a patient with hereditary ATTR amyloidosis","volume":"10","author":"Schmidt","year":"2019","journal-title":"Nat Commun."},{"key":"2021051712150072000_61.7.965.30","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.113.301273"},{"key":"2021051712150072000_61.7.965.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbapap.2010.04.001"},{"key":"2021051712150072000_61.7.965.32","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-156-39920"},{"key":"2021051712150072000_61.7.965.33","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-013-2375-1"},{"key":"2021051712150072000_61.7.965.34","doi-asserted-by":"publisher","DOI":"10.3109\/13506129.2013.797890"},{"key":"2021051712150072000_61.7.965.35","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12585"},{"key":"2021051712150072000_61.7.965.36","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-010-0695-1"},{"key":"2021051712150072000_61.7.965.37","doi-asserted-by":"publisher","DOI":"10.3109\/03009734.2015.1122687"},{"key":"2021051712150072000_61.7.965.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2019.10.015"},{"key":"2021051712150072000_61.7.965.39","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s12350-015-0261-x","article-title":"Serial scanning with technetium pyrophosphate (99mTc-PYP) in advanced ATTR cardiac amyloidosis","volume":"23","author":"Casta\u00f1o","year":"2016","journal-title":"J Nucl Cardiol."},{"key":"2021051712150072000_61.7.965.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.08.067"},{"key":"2021051712150072000_61.7.965.41","doi-asserted-by":"crossref","unstructured":"Layoun ME Desmarais J Heitner SB Masri A . Hot hearts on bone scintigraphy are not all amyloidosis: hydroxychloroquine-induced restrictive cardiomyopathy. Eur Heart J. February 20, 2020.","DOI":"10.1093\/eurheartj\/ehaa091"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.120.245381","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T16:47:41Z","timestamp":1621270061000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.120.245381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,1]]},"references-count":41,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7,1]]},"published-print":{"date-parts":[[2020,7]]}},"alternative-id":["10.2967\/jnumed.120.245381"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.120.245381","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,1]]}}}